Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kohl

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Current Opinion in Chemical Biology|August 1, 1997
Farnesyltransferase inhibitors versus Ras inhibitorsJ B Gibbs, S L Graham, G D Hartman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilonesM M Moasser, L Sepp-Lorenzino, N E Kohl, et al.
Cancer Research|March 27, 1998
Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic miceR Mangues, T Corral, N E Kohl, et al.
The Journal of Biological Chemistry|October 5, 1990
Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 proteaseC L DiIanni, L J Davis, M K Holloway, et al.
Cancer Cell|July 19, 2005
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippageWeikang Tao, Victoria J South, Yun Zhang, et al.
The British Journal of Dermatology|March 16, 2006
In vitro and in vivo comparison of two different light sources for topical photodynamic therapyP Babilas, E Kohl, T Maisch, et al.
The British Journal of Dermatology|February 15, 2012
Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapyR M Szeimies, L Torezan, A Niwa, et al.
Molecular and Cellular Biology|June 1, 1994
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeletonG C Prendergast, J P Davide, S J deSolms, et al.
The Journal of Biological Chemistry|July 15, 1992
cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylaseS Jia, W J VanDusen, R E Diehl, et al.
Biochemistry|May 18, 1993
Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferasesC A Omer, A M Kral, R E Diehl, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Current Opinion in Chemical Biology|August 1, 1997
Farnesyltransferase inhibitors versus Ras inhibitorsJ B Gibbs, S L Graham, G D Hartman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilonesM M Moasser, L Sepp-Lorenzino, N E Kohl, et al.
Cancer Research|March 27, 1998
Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic miceR Mangues, T Corral, N E Kohl, et al.
The Journal of Biological Chemistry|October 5, 1990
Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 proteaseC L DiIanni, L J Davis, M K Holloway, et al.
Cancer Cell|July 19, 2005
Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippageWeikang Tao, Victoria J South, Yun Zhang, et al.
The British Journal of Dermatology|March 16, 2006
In vitro and in vivo comparison of two different light sources for topical photodynamic therapyP Babilas, E Kohl, T Maisch, et al.
The British Journal of Dermatology|February 15, 2012
Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapyR M Szeimies, L Torezan, A Niwa, et al.
Molecular and Cellular Biology|June 1, 1994
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeletonG C Prendergast, J P Davide, S J deSolms, et al.
The Journal of Biological Chemistry|July 15, 1992
cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylaseS Jia, W J VanDusen, R E Diehl, et al.
Biochemistry|May 18, 1993
Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferasesC A Omer, A M Kral, R E Diehl, et al.
Pageof 13